Related Experiment Video

Updated: Aug 8, 2026

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption
12:43

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption

Published on: August 16, 2016

[Effect of L-DOPA on cyclic adenosine-3',5'-monophosphate in neurogenically damaged cardiac muscle]

P P Minin

    Biulleten' Eksperimental'Noi Biologii I Meditsiny
    |July 1, 1980
    PubMed

    Insights

    L-DOPA administration prevented a drop in cyclic adenosine-3

    Area of Science:

    • Pharmacology
    • Cardiovascular Physiology
    • Biochemistry

    Context:

    • Electric stimulation of the aortal reflexogenic zone in rabbits can alter physiological parameters.
    • Cyclic adenosine-3',5'-monophosphate (cAMP) plays a crucial role in cardiac function and vascular regulation.
    • Understanding the effects of L-DOPA on catecholamine pathways is important for cardiovascular research.

    Purpose:

    • To investigate the effect of L-DOPA on cyclic adenosine-3',5'-monophosphate (cAMP) levels during aortal reflexogenic zone stimulation.
    • To explore the potential mechanism by which L-DOPA influences cAMP levels in cardiac muscle and blood plasma.

    Summary:

    • Electric stimulation of the aortal reflexogenic zone in rabbits led to a reduction in cardiac and plasma cyclic adenosine-3',5'-monophosphate (cAMP) levels.
    • Administration of L-DOPA counteracted this reduction, maintaining normal cAMP levels.
    • This protective effect is attributed to L-DOPA's role in endogenous catecholamine biosynthesis, thereby stimulating cAMP synthesis.

    Impact:

    • Provides insights into the neurochemical regulation of cardiovascular responses.
    • Highlights the potential of L-DOPA in modulating cAMP-mediated signaling pathways in the cardiovascular system.
    • Suggests a mechanism for L-DOPA's influence on cardiac and vascular function during autonomic stimulation.

    More Related Videos

    Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential07:41

    Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

    Published on: January 18, 2019

    Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices09:35

    Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

    Published on: June 16, 2020

    Related Concept Videos

    Drugs Affecting Neurotransmitter Synthesis01:29

    Drugs Affecting Neurotransmitter Synthesis

    Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
    Pathophysiology of Cardiac Performance01:29

    Pathophysiology of Cardiac Performance

    Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
    Heart Failure Drugs: Inotropic Agents01:26

    Heart Failure Drugs: Inotropic Agents

    Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
    Heart Failure Drugs: β-Blockers01:22

    Heart Failure Drugs: β-Blockers

    β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...